Feeds:
Posts
Comments

Posts Tagged ‘New York Times’

NEW YORK TIMES: Arnold Palmer led the charge in popularizing golf in the United States in the 1950s and now, in retirement, he is in the vanguard of another movement: educating the public about prostate cancer. READ MORE>

Read Full Post »

NEW YORK TIMES: Invasion of the Prostate Snatchers, by Ralph H. Blum and Dr. Mark Scholz, is a provocative and frank look at the bewildering world of prostate cancer, from the current state of the multi-billion-dollar industry to the range of available treatments. READ MORE>

Read Full Post »

NEW YORK TIMES: The American Cancer Society, which has long been a staunch defender of most cancer screening, is now saying that the benefits of detecting many cancers, especially breast and prostate, have been overstated. READ MORE>

Read Full Post »

NEW YORK TIMES: A nonprofit group in Washington has filed a lawsuit against Bayer Healthcare charging that the company’s labels and commercials falsely claimed its One A Day multi-vitamins for men may reduce the risk of prostate cancer. READ MORE>

Read Full Post »

DanaJenningsNEW YORK TIMES: Depression – a possible aftermath of treatment for a quarter of cancer patients – is described in graphic terms by Dana Jennings, a NYT editor who’s a year into treatment for prostate cancer.

He writes:

I’m depressed.

I’m recovering well from an aggressive case of prostate cancer, I haven’t had any treatment in months, and all of my physical signposts of health are pointing in the right direction. Still, I’m depressed. READ MORE>

Read Full Post »

NEW YORK TIMES: The death of Senator Edward Kennedy from a brain tumour is a reminder that relatively little progress has been made in the cancer death rate in four decades, despite the many billions spent on research. READ MORE>

Senator Edward Kennedy was instrumental in promoting the idea of a “war on cancer,” before President Nixon made the medical challenge a public health research priority in 1971.

Read Full Post »

NEW YORK TIMES: Researchers have discovered a way to identify drugs that can specifically attack and kill cancer stem cells, a finding that could lead to a new generation of anti-cancer medicines and a new strategy of treatment. READ MORE>

Read Full Post »

Older Posts »